Citations

Clear

6273 citation(s) found for "To, Andrew".

Inclusion‐body myositis presenting with facial diplegia
Ghosh, Partha S. , Laughlin, Ruple S. , Engel, Andrew G.

Mayo Clinic

Muscle & Nerve | August 27, 2013 | Volume: 49 | Issue: 2 | Pages: 287-289

10.1002/mus.24060 | PMID 24038039 Get It

ABSTRACTIntroduction: The hallmark clinical presentation of inclusion‐body myositis (IBM) is slowly progressive weakness that characteristically affects the quadriceps and finger and wrist finger flexor muscles. Facial weakness can also occur, but it is typically mild and not a prominent finding. Methods: We describe the clinical features, laboratory investigations, and muscle biopsy findings in a 58‐year old man who presented with a 6‐year history of marked progressive symmetrical facial weakness. Examination also showed shoulder abduction and hip extensor weakness. Results: The patient's serum creatine kinase level was 655 U/L, and electromyography showed fibrillation potentials and myopathic motor unit potentials. A biopsy specimen of the left biceps muscle was pathognomonic for IBM. Conclusions: This patient did not have a typical presentation for IBM but rather fulfilled the pathological criteria for IBM. To our knowledge, facial diplegia has not been reported previously as a presenting manifestation of IBM. Muscle Nerve 49: 287–289, 2014
Thromboxane A2 Generation, in the Absence of Platelet COX-1 Activity, in Patients With and Without Atherothrombotic Myocardial Infarction
DeFilippis, Andrew P. , Oloyede, Oluwasegun S., Andrikopoulou, Efstathia , Saenger, Amy K., Palachuvattil, Joel M., Fasoro, Yetunde A., Kickler, Thomas S. , Jaffe, Allan S. , Schulman, Steven P. , Rade, Jeffrey J. , Güallar, Eliseo , Blumenthal, Roger S. , Jaffe, Allan S. , Gerstenblith, Gary

Mayo Clinic

Circulation Journal | August 26, 2013 | Volume: 77 | Issue: 11 | Pages: 2786-2792

10.1253/circj.cj-12-1421 | PMID 23985963 Get It

Tumor‐Induced Osteomalacia Resulting from Primary Cutaneous Phosphaturic Mesenchymal Tumor: A Case and Review of the Medical Literature
Shon, Wonwoo , Folpe, Andrew L. , Wieland, Carilyn N. , Tebben, Peter J. , Baum, Christian L. , Gardner, Kevin H, Gardner, Kevin H. , Tebben, Peter

Mayo Clinic

Journal of Cutaneous Pathology | August 21, 2013 | Volume: 40 | Issue: 9 | Pages: 780-784

10.1111/cup.12209 | PMID 23962115 Get It

Percutaneous Coronary Intervention in Pediatric and Adolescent Patients
Schneider, Andrew E. , Johnson, Jonathan N. , Taggart, Nathaniel W. , Hagler, Donald J. , Reeder, Guy S., Cetta, Frank , Cabalka, Allison K. , Taggart, Nathaniel W

Mayo Clinic

Congenital Heart Disease | August 16, 2013 | Volume: 9 | Issue: 3 | Pages: 228-234

10.1111/chd.12130 | PMID 23947956 Get It

Tendon gradient mineralization for tendon to bone interface integration
Thoreson, Andrew R. , Chen, Qingshan , An, Kai‐Nan, Amadio, Peter C. , Zhao, Chunfeng , Qu, Jin, Qu, Jin , An, Kai‐Nan

Mayo Clinic

Journal of Orthopaedic Research | August 12, 2013 | Volume: 31 | Issue: 11 | Pages: 1713-1719

10.1002/jor.22412 | PMID 23939935 Get It

AbstractTendon‐to‐bone integration is a great challenge for tendon or ligament reconstruction regardless of use of autograft or allograft tendons. We mineralized the tendon, thus transforming the tendon‐to‐bone into a “bone‐to‐bone” interface for healing. Sixty dog flexor digitorum profundus (FDP) tendons were divided randomly into five groups: (1) normal FDP tendon, (2) CaP (non‐extraction and mineralization without fetuin), (3) CaPEXT (Extraction by Na2HPO4 and mineralization without fetuin), (4) CaPFetuin (non‐extraction and mineralization with fetuin), and (5) CaPEXTFetuin (extraction and mineralization with fetuin). The calcium and phosphate content significantly increased in tendons treated with combination of extraction and fetuin compared to the other treatments. Histology also revealed a dense mineral deposition throughout the tendon outer layers and penetrated into the tendon to a depth of 200 µm in a graded manner. Compressive moduli were significantly lower in the four mineralized groups compared with normal control group. No significant differences in maximum failure strength or stiffness were found in the suture pull‐out test among all groups. Mineralization of tendon alters the interface from tendon to bone into mineralized tendon to bone, which may facilitate tendon‐to‐bone junction healing following tendon or ligament reconstruction. © 2013 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31:1713–1719, 2013
Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia
Kocarnik, Jonathan , Lindor, Noralane M. , Chang‐Claude, Jenny , Caberto, Christian, Love, Shelly-Ann, Slattery, Martha L. , Hindorff, Lucia A. , Park, Sungshim Lani, Schumacher, Fredrick R. , Hoffmeister, Michael , Duggan, David , Hou, Lifang , Carlson, Chris , Carty, Cara L. , Mann, Sue, Giovannucci, Edward L. , Fuchs, Charles S. , Jenkins, Mark A. , Haile, Robert W. , Conti, David V. , Potter, John D. , Caan, Bette J. , Hayes, Richard B. , Berndt, Sonja I. , Küry, Sébastien , Bezieau, Stéphane , Ambite, José Luis , Kumaraguruparan, Gowri, Richardson, Danielle , Goodloe, Robert, Dilks, Holli H., Baker, Paxton, Zanke, Brent W., Lemire, Mathieu , Gallinger, Steven , Jiao, Shuo , Harrison, Tabitha A. , Seminara, Daniela, Haiman, Christopher A. , Hutter, Carolyn M., Crawford, Dana C. , Heiss, Gerardo , Brenner, Hermann , Bush, William S. , Casey, Graham , Peters, Ulrike , Cheng, Iona C. , Dumitrescu, Logan , Avery, Christy L. , Chan, Andrew T. , Baron, John A. , Kraft, Peter , Butler, Anne Marie E. , Monroe, Kristine R. , Lin, Yi , Ma, Jing , Newcomb, Polly A. , Hopper, John L. , Campbell, Peter T. , Schoen, Robert E. , Chanock, Stephen Jacob , Hsu, Li , Kooperberg, Charles , Wilkens, Lynne R. , White, Emily E. , Hudson, Thomas J , Marchand, Loı̈c Le , Hoffmeister, Michael , Jenkins, Mark A , Haile, Robert W , Harrison, Tabitha A , Potter, John D , Kury, Sebastien , Brenner, Hermann , Hayes, Richard B , Bézieau, Stéphane , Conti, David V , Hou, Lifang , Caan, Bette J , Bush, William S

Mayo Clinic

Gut | August 10, 2013 | Volume: 63 | Issue: 5 | Pages: 800-807

10.1136/gutjnl-2013-305189 | PMID 23935004 Get It

Objective Genome-wide association studies have identified a large number of single nucleotide polymorphisms (SNPs) associated with a wide array of cancer sites. Several of these variants demonstrate associations with multiple cancers, suggesting pleiotropic effects and shared biological mechanisms across some cancers. We hypothesised that SNPs previously associated with other cancers may additionally be associated with colorectal cancer. In a large-scale study, we examined 171 SNPs previously associated with 18 different cancers for their associations with colorectal cancer. Design We examined 13 338 colorectal cancer cases and 40 967 controls from three consortia: Population Architecture using Genomics and Epidemiology (PAGE), Genetic Epidemiology of Colorectal Cancer (GECCO), and the Colon Cancer Family Registry (CCFR). Study-specific logistic regression results, adjusted for age, sex, principal components of genetic ancestry, and/or study specific factors (as relevant) were combined using fixed-effect meta-analyses to evaluate the association between each SNP and colorectal cancer risk. A Bonferroni-corrected p value of 2.92×10 −4 was used to determine statistical significance of the associations. Results Two correlated SNPs—rs10090154 and rs4242382—in Region 1 of chromosome 8q24, a prostate cancer susceptibility region, demonstrated statistically significant associations with colorectal cancer risk. The most significant association was observed with rs4242382 (meta-analysis OR=1.12; 95% CI 1.07 to 1.18; p=1.74×10 −5 ), which also demonstrated similar associations across racial/ethnic populations and anatomical sub-sites. Conclusions This is the first study to clearly demonstrate Region 1 of chromosome 8q24 as a susceptibility locus for colorectal cancer; thus, adding colorectal cancer to the list of cancer sites linked to this particular multicancer risk region at 8q24.
Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications
Chen, Honglei , Ross, G. Webster , Huang, Xuemei , Savica, Rodolfo , Abbott, Robert D. , Ascherio, Alberto , Caviness, John N., Gao, Xiang , Gray, Kimberly , Hong, Jau‐Shyong , Kamel, Freya , Jennings, Danna , Kirshner, Annette, Lawler, Cindy P., Liu, Rui , Nussbaum, Robert , Peddada, Shyamal D. , Rick, Amy Comstock, Ritz, Beate , Siderowf, Andrew , Tröster, Alexander I. , Zhang, Jing , Burton, Edward A. , Miller, Gary W. , Tanner, Caroline M.

Mayo Clinic

Environmental Health Perspectives | August 9, 2013 | Volume: 121 | Issue: 11-12 | Pages: 1245-1252

10.1289/ehp.1306967 | PMID 23933572 Get It

Abstract Background: The etiology and natural history of Parkinson’s disease (PD) are not well understood. Some non-motor symptoms such as hyposmia, rapid eye movement sleep behavior disorder, and constipation may develop during the prodromal stage of PD and precede PD diagnosis by years. Objectives: We examined the promise and pitfalls of research on premotor symptoms of PD and developed priorities and strategies to understand their clinical and etiological implications. Methods: This review was based on a workshop, Parkinson’s Disease Premotor Symptom Symposium, held 7–8 June 2012 at the National Institute of Environmental Health Sciences in Research Triangle Park, North Carolina. Discussion: Research on premotor symptoms of PD may offer an excellent opportunity to characterize high-risk populations and to better understand PD etiology. Such research may lead to evaluation of novel etiological hypotheses such as the possibility that environmental toxicants or viruses may initiate PD pathogenesis in the gastrointestinal tract or olfactory bulb. At present, our understanding of premotor symptoms of PD is in its infancy and faces many obstacles. These symptoms are often not specific to PD and have low positive predictive value for early PD diagnosis. Further, the pathological bases and biological mechanisms of these premotor symptoms and their relevance to PD pathogenesis are poorly understood. Conclusion: This is an emerging research area with important data gaps to be filled. Future research is needed to understand the prevalence of multiple premotor symptoms and their etiological relevance to PD. Animal experiments and mechanistic studies will further understanding of the biology of these premotor symptoms and test novel etiological hypothesis. Citation: Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbott RD, Ascherio A, Caviness JN, Gao X, Gray KA, Hong JS, Kamel F, Jennings D, Kirshner A, Lawler C, Liu R, Miller GW, Nussbaum R, Peddada SD, Comstock Rick A, Ritz B, Siderowf AD, Tanner CM, Tröster AI, Zhang J. 2013. Research on the premotor symptoms of Parkinson’s Disease: clinical and etiological implications. Environ Health Perspect 121:1245–1252; http://dx.doi.org/10.1289/ehp.1306967
Multicenter trial of the proficiency of smart quantitative sensation tests
Dyck, P. James B. , Argyros, Barbara, Russell, James W. , Gahnstrom, Linde E., Nalepa, Susan, Albers, James W., Lodermeier, Karen A., Zafft, Andrew J., Klein, Christopher J. , Litchy, William J. , Davies, Jenny L., Carter, Rickey E. , Melton, L. Joseph , (Appendix), members of the Cl versus NPhys Trials, Tesfaye, Solomon , (Appendix), members of the Cl versus NPhys Trials, Klein, Christopher J , Carter, Rickey E

Mayo Clinic

Muscle & Nerve | August 8, 2013 | Volume: 49 | Issue: 5 | Pages: 645-653

10.1002/mus.23982 | PMID 23929701 Get It

ABSTRACTIntroduction: We assessed proficiency (accuracy and intra‐ and intertest reproducibility) of smart quantitative sensation tests (smart QSTs) in subjects without and with diabetic sensorimotor polyneuropathy (DSPN). Methods: Technologists from 3 medical centers using different but identical QSTs independently assessed 6 modalities of sensation of the foot (or leg) twice in patients without (n = 6) and with (n = 6) DSPN using smart computer assisted QSTs. Results: Low rates of test abnormalities were observed in health and high rates in DSPN. Very high intraclass correlations were obtained between continuous measures of QSTs and neuropathy signs, symptoms, or nerve conductions (NCs). No significant intra‐ or intertest differences were observed. Conclusions: These results provide proof of concept that smart QSTs provide accurate assessment of sensation loss without intra‐ or intertest differences useful for multicenter trials. Smart technology makes possible efficient testing of body surface area sensation loss in symmetric length‐dependent sensorimotor polyneuropathies. Muscle Nerve 49: 645–653, 2014
GABA B receptor autoantibody frequency in service serologic evaluation
Jeffery, Oliver J., Lennon, Vanda A. , Pittock, Sean J. , Gregory, Jeremy K., McKeon, Andrew , Britton, Jeffrey W. , Pittock, S J , McKeon, Andrew

Mayo Clinic

Neurology | August 8, 2013 | Volume: 81 | Issue: 10 | Pages: 882-887

10.1212/wnl.0b013e3182a35271 | PMID 23925760 Get It

Pathological and physiological high-frequency oscillations in focal human epilepsy
Matsumoto, Andrew , Brinkmann, Benjamin H. , Stead, S. Matthew, Matsumoto, Joseph Y., Kucewicz, Michał T. , Marsh, W. Richard , Meyer, Frederic B., Worrell, Gregory A. , Brinkmann, Benjamin H , Kucewicz, Michal

Mayo Clinic

Journal of Neurophysiology | August 7, 2013 | Volume: 110 | Issue: 8 | Pages: 1958-1964

10.1152/jn.00341.2013 | PMID 23926038 Get It

High-frequency oscillations (HFO; gamma: 40–100 Hz, ripples: 100–200 Hz, and fast ripples: 250–500 Hz) have been widely studied in health and disease. These phenomena may serve as biomarkers for epileptic brain; however, a means of differentiating between pathological and normal physiological HFO is essential. We categorized task-induced physiological HFO during periods of HFO induced by a visual or motor task by measuring frequency, duration, and spectral amplitude of each event in single trial time-frequency spectra and compared them to pathological HFO similarly measured. Pathological HFO had higher mean spectral amplitude, longer mean duration, and lower mean frequency than physiological-induced HFO. In individual patients, support vector machine analysis correctly classified pathological HFO with sensitivities ranging from 70–98% and specificities >90% in all but one patient. In this patient, infrequent high-amplitude HFO were observed in the motor cortex just before movement onset in the motor task. This finding raises the possibility that in epileptic brain physiological-induced gamma can assume higher spectral amplitudes similar to those seen in pathologic HFO. This method if automated and validated could provide a step towards differentiating physiological HFO from pathological HFO and improving localization of epileptogenic brain.